Pro-Dex, Inc. (PDEX)
$17.2
-0.51 (-2.88%)
Rating:
Recommendation:
Buy
| Symbol | PDEX |
|---|---|
| Price | $17.2 |
| Beta | 0.955 |
| Volume Avg. | 0.01M |
| Market Cap | 61.582M |
| Shares () | - |
| 52 Week Range | 12.4-26.51 |
| 1y Target Est | - |
| DCF Unlevered | PDEX DCF -> | |
|---|---|---|
| DCF Levered | PDEX LDCF -> | |
| ROE | 16.75% | Buy |
| ROA | 8.06% | Neutral |
| Operating Margin | - | |
| Debt / Equity | 96.45% | Buy |
| P/E | 16.70 | Strong Buy |
| P/B | 2.55 | Strong Buy |
Latest PDEX news
About
Download (Excel)Mr. Richard Van Kirk
Healthcare
Medical Instruments & Supplies
NASDAQ Capital Market
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.